SMT · NSE · Mainboard
Sahajanand Medical Technologies Limited.
View on Screener ↗Unclassified · Closed
Financial Performance
Amounts in ₹ crore; EPS in ₹ per share. PAT is total profit for the period, including non-controlling interests. Standalone statements.
Source temporarily unavailable for this period and basis.
01 · UNDERSTAND THE BUSINESS
The company in 60 seconds
Sahajanand Medical Technologies develops, manufactures, and markets cardiovascular devices globally. The core business is divided into two primary segments: vascular intervention products, such as coronary stents and balloon catheters, and structural heart devices, including transcatheter aortic valves and occluders. The company generates the majority of its revenue from the sale of vascular intervention devices, with the Supraflex Cruz, a biodegradable polymer-based drug-eluting stent, acting as a major contributor to its sales. Products are distributed across India, Europe, and the rest of the world through a combination of direct, hybrid, and distributor-led models, supported by an extensive network of domestic and international distributors. Operations are backed by manufacturing facilities located in Surat, Hyderabad, and Thailand. Additionally, the business relies heavily on dedicated research and development capabilities to continually enhance existing products and introduce new cardiovascular treatments.
What supports the business
- Strong portfolio of vascular and structural heart medical devices
- Extensive domestic and international distribution network
- Dedicated in-house research and development capabilities
- Multiple manufacturing facilities across India and Thailand
- Diversified revenue streams from sales in over 65 countries
What could go wrong
- High dependency on revenues from the Supraflex Cruz stent
- Stringent domestic and global regulatory compliance requirements
- Vulnerability to foreign currency exchange rate fluctuations
- Reliance on limited third-party suppliers for key raw materials
- Exposure to pricing controls and healthcare reimbursement caps
Where will the IPO money go?
Use of proceeds is awaiting review.
Fresh issue proceeds go to the company. Offer-for-sale proceeds go to the selling shareholders.
Provider content · IPOALERTS · Not independently reviewed · Retrieved 17 Oct 2026, 11:00 pm IST · Data source ↗
A research starting point, not an apply/avoid recommendation.
02 · PREPARE YOUR APPLICATION
How much will be blocked?
Category rules pending · Mainboard
Applications are closed. This is a reference calculation.
Application rules are awaiting review. Check the issue prospectus or your broker.
Before you finish applying 0/5
Your personal checklist for this visit. MeraIPO cannot verify or submit an application.
All checked? This still does not guarantee allotment. If a UPI mandate is missing, contact the broker or intermediary you used. ASBA through a bank may not use UPI.
Application help from NSE ↗03 · KEEP TRACK
Dates that matter
Tentative · check for changes- Applications open15 Oct 2026
- Applications close19 Oct 2026
- Accept UPI mandate byTo be announced
- Allotment expectedTo be announced
- Unblocking startsTo be announced
- Expected listing23 Oct 2026
All times are IST. Your broker may stop accepting bids earlier. Unblocking is an initiation date; bank processing times can differ.
Add dates to calendar ↓Import these dates into your calendar. Saved dates will not update automatically if the schedule changes.
Full provider schedule
- Issue open date: 15 Oct 2026
- Issue close date: 19 Oct 2026
- UPI mandate deadline: 19 Oct 2026
- Allotment finalization: 21 Oct 2026
- Refund initiation: 22 Oct 2026
- Share credit: 22 Oct 2026
- Listing date: 23 Oct 2026
- Mandate end date: 3 Nov 2026
- Lock-in end date for anchor investors (50%): 19 Nov 2026
- Lock-in end date for anchor investors (remaining): 18 Jan 2027
Dates supplied by IPOALERTS; no deadline time was provided. Check the issue source.
Did you get shares?
The official registrar link is awaiting verification.
UPI mandate missing?
Check your UPI app and application status with the broker or bank you used. Contact that intermediary before the applicable deadline. Submitting a bid alone does not confirm that funds were blocked.
NSE application guidance ↗Market interest
Subscription
- Institutional (QIB)
- 34.7×
- Nii
- 14.64×
- Retail applicants
- 3.03×
- Employee
- 0.37×
- Total
- 14.2×
Bids received relative to shares offered. Higher subscription does not guarantee returns.
Updated 19 Oct 2026, 7:00 pm IST · NSE_CONSOLIDATED ↗
Unofficial GMP
₹24
Implied price: ₹368
An unofficial indication, not an exchange quote or a forecast. Listing prices may differ substantially.
19 Oct 2026, 10:55 pm IST · Stale
Financial history & source documents
BUSINESS VS PRICE
Insufficient Data / Price pending
Two comparable YoY results and EBITDA margins are required.
The quarterly journey
₹ Cr except EPS and ratios| Financial metric | IPO baseline |
|---|---|
| Revenue | — |
| Revenue YoY | — |
| Revenue QoQ | — |
| EBITDA | — |
| EBITDA YoY | — |
| EBITDA QoQ | — |
| EBITDA margin | — |
| Margin change QoQ (bps) | — |
| Margin change YoY (bps) | — |
| PAT | — |
| PAT YoY | — |
| PAT QoQ | — |
| EPS (₹) | — |
| Operating cash flow | — |
| Debt | — |
| ROE | — |
| ROCE | — |
Quarterly results are not available yet. The original IPO baseline is retained separately.
“—” means unavailable, not zero. Year-on-year growth requires a positive comparable period. Cash flow is shown only when reported for that period.
Annual financial history · latest four years
Separate from the original pre-IPO baseline. Amounts in ₹ crore; EPS in ₹.
No annual filings have been imported yet.
Stock journey
- Listing price
- —
- Since listing
- —
- All-time high
- —
- 52-week high / low
- — / —
Valuation snapshot
Data unavailable
- IPO P/E
- —
- Current P/E
- —
- Peer median P/E
- —
- Market cap (₹ Cr)
- —
- EV / EBITDA
- —
Sources & further research
Filing sources & update times
Source and verification record
Rhp url ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Exchange url ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Issue size ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Lot size ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Price high ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Price low ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Listing date ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Close date ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Open date ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Status ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Exchange ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Board ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Sector ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Name ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Slug ↗ · Unverified · 17 Oct 2026, 11:01 pm IST
Rhp url ↗ · Unverified · 16 Oct 2026, 5:13 pm IST
Exchange url ↗ · Unverified · 16 Oct 2026, 5:13 pm IST
Issue size ↗ · Unverified · 16 Oct 2026, 5:13 pm IST
Lot size ↗ · Unverified · 16 Oct 2026, 5:13 pm IST
Price high ↗ · Unverified · 16 Oct 2026, 5:13 pm IST